WFDC2 and ovarian carcinoma: Serum HE4 levels were significantly elevated in women with ovarian cancer compared to those without [213.6 pmol/L (IQR: 149.0–295.8) vs. 75.7 pmol/L (IQR: 61.4–93.5), p < 0.001].